Bisphenol S causes excessive estrogen synthesis by activating FSHR and the downstream cAMP/PKA signaling pathway

Estrogen excess in females has been linked to a diverse array of chronic and acute diseases. Emerging research shows that exposure to estrogen-like compounds such as bisphenol S leads to increases in 17 β -estradiol levels, but the mechanism of action is unclear. The aim of this study was to reveal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Communications biology 2024-07, Vol.7 (1), p.844-12, Article 844
Hauptverfasser: Zhang, Xiaorong, Zhang, Xinda, Zhang, Zhenzhong, Shi, Yijiao, Wang, Jun, Ru, Shaoguo, Tian, Hua
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Estrogen excess in females has been linked to a diverse array of chronic and acute diseases. Emerging research shows that exposure to estrogen-like compounds such as bisphenol S leads to increases in 17 β -estradiol levels, but the mechanism of action is unclear. The aim of this study was to reveal the underlying signaling pathway-mediated mechanisms, target site and target molecule of action of bisphenol S causing excessive estrogen synthesis. Human ovarian granulosa cells SVOG were exposed to bisphenol S at environmentally relevant concentrations (1 μg/L, 10 μg/L, and 100 μg/L) for 48 h. The results confirms that bisphenol S accumulates mainly on the cell membrane, binds to follicle stimulating hormone receptor (FSHR) located on the cell membrane, and subsequently activates the downstream cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) signaling pathway, leading to enhanced conversion of testosterone to 17 β -estradiol. This study deepens our knowledge of the mechanisms of environmental factors in pathogenesis of hyperestrogenism. This study deepens the knowledge of mechanisms of environmental factors in pathogenesis of hyperestrogenism, which is indispensable for the prevention and treatment of hyperestrogenism and a diverse array of hyper-estrogen activity-driven diseases.
ISSN:2399-3642
2399-3642
DOI:10.1038/s42003-024-06449-2